Analyzing Hims & Hers Health (NYSE:HIMS) and Pono Capital Two (NASDAQ:PTWO)

Hims & Hers Health (NYSE:HIMS) and Pono Capital Two (NASDAQ:PTWO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, analyst recommendations, earnings, institutional ownership and profitability.

Valuation & Earnings

This table compares Hims & Hers Health and Pono Capital Two’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$872.00 million	3.04	-$23.55 million	($0.11)	-112.55
Pono Capital Two	N/A	N/A	$340,000.00	N/A	N/A

Pono Capital Two has lower revenue, but higher earnings than Hims & Hers Health.

Risk and Volatility

Hims & Hers Health has a beta of 0.91, suggesting that its stock price is 9% less volatile than the S&P 500. Comparatively, Pono Capital Two has a beta of 0.11, suggesting that its stock price is 89% less volatile than the S&P 500.

Profitability

This table compares Hims & Hers Health and Pono Capital Two’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-2.70%	-7.21%	-5.81%
Pono Capital Two	N/A	-6.63%	0.73%

Analyst Ratings

This is a summary of current ratings and recommmendations for Hims & Hers Health and Pono Capital Two, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	0	5	8	0	2.62
Pono Capital Two	0	0	0	0	N/A

Hims & Hers Health presently has a consensus price target of $14.85, suggesting a potential upside of 19.92%. Given Hims & Hers Health’s higher possible upside, equities research analysts plainly believe Hims & Hers Health is more favorable than Pono Capital Two.

Insider and Institutional Ownership

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 60.8% of Pono Capital Two shares are held by institutional investors. 31.6% of Hims & Hers Health shares are held by insiders. Comparatively, 63.9% of Pono Capital Two shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

About Pono Capital Two

Pono Capital Two, Inc. does not have any significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2022 and is based in Honolulu, Hawaii.